Related Experiment Videos
Loss of p53 expression in Myc-induced B lineage tumors
1Department of Pathology, University of Texas Southwestern Medical Center, Dallas 75235-9072.
Abstract:
Tumors are formed following the accumulation of several genetic changes in genes which normally function to regulate cell growth. As yet it is unclear why multiple mutations are required, which type of alterations can collaborate with each other, and if collaboration is cell-type specific. In our myc transgenic mouse model system both point mutations and loss of mRNA expression for the p53 tumor suppressor gene have been found in the myc-induced B-lineage tumors arising spontaneously in these mice. This demonstrates the collaboration between these two growth control genes in cellular transformation. The observation that alterations in the expression of p53 is a common phenomenon in tumors formed in myc transgenic mice as well as a variety of different types of human tumors suggests that inactivation of the p53 growth control pathway may be required for transformation, and that alterations in p53 itself might be the most efficient way to achieve this inactivation. An analysis of the molecular mechanism for p53 alterations has implications for what kind of factors, both environmental and physiological, can influence tumor formation. The identification of collaboration groups has implications for the process of tumor formation, growth regulation, and will some day be important for the diagnosis of cancer, the prognosis of the individual and the design of specific therapeutic agents for treatment.
Insights
Tumorigenesis requires multiple genetic changes. This study shows that alterations in the p53 tumor suppressor gene collaborate with myc in B-lineage tumors, suggesting p53 inactivation is crucial for cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Tumorigenesis arises from accumulated genetic alterations in cell growth regulatory genes.
- The necessity for multiple mutations, their collaborative potential, and cell-type specificity remain unclear.
- The myc oncogene drives B-lineage tumor formation in specific mouse models.
Purpose of the Study:
- To investigate the collaboration between genetic alterations in tumor suppressor genes and oncogenes during tumorigenesis.
- To determine if p53 alterations collaborate with myc in B-lineage tumor development.
- To explore the role of p53 inactivation in cellular transformation and its implications for cancer.
Main Methods:
- Utilized a myc transgenic mouse model system.
- Analyzed spontaneous B-lineage tumors arising in these mice.
- Examined genetic alterations, including point mutations and loss of mRNA expression, for the p53 tumor suppressor gene.
Main Results:
- Demonstrated collaboration between myc and p53 alterations in cellular transformation within B-lineage tumors.
- Observed frequent alterations in p53 expression in tumors from myc transgenic mice.
- Found p53 alterations in various human tumor types, suggesting a common pathway for inactivation.
Conclusions:
- Inactivation of the p53 tumor suppressor pathway is likely essential for cellular transformation.
- Alterations in p53 may be the most efficient mechanism for achieving pathway inactivation.
- Understanding p53 alteration mechanisms and gene collaboration has implications for cancer diagnosis, prognosis, and therapeutic strategies.